Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma

医学 安慰剂 临床终点 短尾鱼 内科学 脊索瘤 危险系数 胃肠病学 肿瘤科 置信区间 随机对照试验 免疫学 外科 病理 生物 胚胎干细胞 基因 替代医学 中胚层 生物化学
作者
Peter J. DeMaria,Marijo Bilušić,Deric M. Park,Christopher R. Heery,Renee N. Donahue,Ravi A. Madan,Mohammad Hadi Bagheri,Julius Strauss,Victoria Shen,Jennifer L. Marté,Seth M. Steinberg,Jeffrey Schlom,Mark R. Gilbert,James L. Gulley
出处
期刊:Oncologist [AlphaMed Press]
卷期号:26 (5): e847-e858 被引量:37
标识
DOI:10.1002/onco.13720
摘要

Brachyury is a transcription factor overexpressed in chordoma and is associated with chemotherapy resistance and epithelial-to-mesenchymal transition. GI-6301 is a recombinant, heat-killed Saccharomyces cerevisiae yeast-based vaccine targeting brachyury. A previous phase I trial of GI-6301 demonstrated a signal of clinical activity in chordomas. This trial evaluated synergistic effects of GI-6301 vaccine plus radiation.Adults with locally advanced, unresectable chordoma were treated on a randomized, placebo-controlled trial. Patients received three doses of GI-6301 (80 × 107 yeast cells) or placebo followed by radiation, followed by continued vaccine or placebo until progression. Primary endpoint was overall response rate, defined as a complete response (CR) or partial response (PR) in the irradiated tumor site at 24 months. Immune assays were conducted to evaluate immunogenicity.Between May 2015 and September 2019, 24 patients enrolled on the first randomized phase II study in chordoma. There was one PR in each arm; no CRs were observed. Median progressive-free survival for vaccine and placebo arms was 20.6 months (95% confidence interval [CI], 5.7-37.5 months) and 25.9 months (95% CI, 9.2-30.8 months), respectively. Hazard ratio was 1.02 (95% CI, 0.38-2.71). Vaccine was well tolerated with no vaccine-related serious adverse events. Preexisting brachyury-specific T cells were detected in most patients in both arms. Most patients developed T-cell responses during therapy, with no difference between arms in frequency or magnitude of response.No difference in overall response rate was observed, leading to early discontinuation of this trial due to low conditional power to detect statistical difference at the planned end of accrual.Chordoma is a rare neoplasm lacking effective systemic therapies for advanced, unresectable disease. Lack of clinically actionable somatic mutations in chordoma makes development of targeted therapy quite challenging. While the combination of yeast-brachyury vaccine (GI-6301) and standard radiation therapy did not demonstrate synergistic antitumor effects, brachyury still remains a good target for developmental therapeutics in chordoma. Patients and their oncologists should consider early referral to centers with expertise in chordoma (or sarcoma) and encourage participation in clinical trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
1秒前
gugugaga发布了新的文献求助10
2秒前
七七完成签到 ,获得积分10
2秒前
Loooong发布了新的文献求助10
3秒前
内向音响完成签到,获得积分10
3秒前
4秒前
zmj完成签到,获得积分10
4秒前
无昵称发布了新的文献求助10
4秒前
5秒前
ma完成签到,获得积分10
5秒前
QQ完成签到,获得积分10
6秒前
zyz发布了新的文献求助10
6秒前
Kriten发布了新的文献求助10
6秒前
打打应助我想@科研采纳,获得10
6秒前
jhih完成签到,获得积分10
7秒前
DokiDoki完成签到,获得积分10
7秒前
cmy关闭了cmy文献求助
7秒前
llllhh完成签到,获得积分10
8秒前
8秒前
非泥完成签到,获得积分10
8秒前
oywt关注了科研通微信公众号
9秒前
一一一发布了新的文献求助10
9秒前
9秒前
9秒前
YANG完成签到 ,获得积分10
10秒前
星际圈完成签到,获得积分10
11秒前
12秒前
Chu_JH完成签到,获得积分10
12秒前
12秒前
12秒前
12秒前
Hyacinth完成签到,获得积分10
12秒前
爆米花应助wst采纳,获得10
12秒前
传奇3应助沉默的宛筠采纳,获得10
12秒前
凪白完成签到,获得积分10
12秒前
taoatao发布了新的文献求助10
13秒前
坚果发布了新的文献求助10
13秒前
13秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970683
求助须知:如何正确求助?哪些是违规求助? 3515337
关于积分的说明 11178055
捐赠科研通 3250580
什么是DOI,文献DOI怎么找? 1795357
邀请新用户注册赠送积分活动 875790
科研通“疑难数据库(出版商)”最低求助积分说明 805166